SCHEMBL2829735

SCHEMBL2829735

O=C(CCn1c(=O)oc2ccccc21)N1CCC(N2CCCC2)CC1

nearest known ligand 0.80

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CDYL2 Q8N8U2 5/20 0.80
▸ CDYL Q9Y232 5/20 0.80
▸ CBX7 O95931 4/20 0.80
▸ CDY1; CDY1B Q9Y6F8 3/20 0.78
▸ ALDH1A1 P00352 5/20 0.77
▸ POLB P06746 2/20 0.63
▸ TSHR P16473 2/20 0.62
▸ L3MBTL1 Q9Y468 2/20 0.61
▸ USP2 O75604 1/20 0.61
▸ LMNA P02545 1/20 0.61
▸ GAA P10253 1/20 0.61
▸ HTT P42858 1/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ MAPT P10636 1/20 0.58
▸ HSD17B10 Q99714 1/20 0.58
▸ MEN1 O00255 1/20 0.57
▸ KMT2A Q03164 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4379269 0.91 ALDH1A1 (0.73) CDYL2CDYLCBX7CDY1; CDY1BALDH1A1
SCHEMBL4386342 0.90 ALDH1A1 (0.75) CDYL2CDYLCBX7CDY1; CDY1BALDH1A1
SCHEMBL4385817 0.82 ALDH1A1 (0.63) CDYL2CDYLCBX7CDY1; CDY1BALDH1A1
SCHEMBL13779939 0.81 ALDH1A1 (0.79) ALDH1A1POLBTSHRL3MBTL1USP2
SCHEMBL4381097 0.76 ALDH1A1 (0.69) ALDH1A1POLBTSHRL3MBTL1USP2
SCHEMBL4386911 0.75 TSHR (0.70) ALDH1A1POLBTSHRL3MBTL1USP2
SCHEMBL12124515 0.74 — —
Hydrochloric Acid SCHEMBL4380692 0.74 TSHR (0.69) ALDH1A1POLBTSHRL3MBTL1USP2
SCHEMBL12124510 0.73 — —
SCHEMBL12124405 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 — — EP claimed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 — — EP disclosed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 — — EP disclosed
US-7064135-B2 Substituted piperidines NOVO NORDISK INC. (DK) 2006-06-20 — — US disclosed
Send feedback